RankAlpha logo
Back to Rankings

TMCI

Treace Medical ConceptsC
Nasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-20
View Chart
Current thesis
The constructive setup is that Treace has already cut cash usage materially, guided to another roughly 50% reduction in 2026 cash usage, posted a preliminary Q1 cash increase, and now has identifiable launch hooks in SuperBite and SpeedXM that could improve surgeon wallet share if execution is clean. [#8-K-2026-04-09] [#PR-2026-04-07]
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -1.3.
What can break
Commercial execution risk increased after the April 8, 2026 chief commercial officer departure disclosed in the 8-K.
Momentum
97
Value
37
Sentiment
27
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $2.20 · Bull $3.80 · Bear $1.30
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $4.67
Why
Momentum97 · Δ7d -1.3
Value37 · Δ7d -0.0
Sentiment27 · Δ7d -0.7
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
97
26% active weight
Current posture
7d trendSoftening
Δ7d
-1.3
Δ21d
-2.0
Value
37
39% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
27
34% active weight
Current posture
7d trendFlat
Δ7d
-0.7
Δ21d
+0.7
Why this grade

Composite grade C. Momentum 97.0 / Value 36.5 / Sentiment 26.9

Fundamentals (TTM)
As of 2026-07-20
Market Cap
$274.41M
Beta
0.74
Shares Out
64.87M
P/E (TTM) · Derived
-4.5
P/S (TTM)
0.77
P/FCF (TTM) · Derived
-10.31
Rev YoY
-10.2%
EPS YoY
+9.4%
Gross Margin
+79.7%
Op Margin
-22.1%
Net Debt
$23.5M
Current Ratio
3.58
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology